Vector Borne Diseases

Total Page:16

File Type:pdf, Size:1020Kb

Vector Borne Diseases 2015 Agricultural Medicine Course October 14, 2015 Vector Borne Illnesses in the Northeast • Lyme disease and others • West Nile Virus infection • Eastern Equine Encephalitis • Powassan virus Encephalitis Christopher Grace, MD, FIDSA Jeffrey Heath, RN Director, Infectious Diseases Unit Vermont Department of Health University of Vermont Medical Center In the US Lyme Disease is Caused by Borrelia burgdoferi • Cork screw shaped motile bacterium (Spirochete) • Able to change the outer surface proteins (OSP) • Fastidious and difficult to culture • Inflammatory symptoms due to host immune response Lyme Diseases is a Worldwide Infection Borrelia burgdoferi B. afzelii; and B. garinii www.thelancet.com Vol 379 February 4, 2012 Two Year Cycle of Black- Legged Tick (Ixodes scapularis) MEAL 1 EGGS LARVAE • Mouse • Bird NYMPHS MEAL 2 (peak feeding Nymphs Eggs laid, time May-mid July) molt into adults die • Person adults • Mouse • Dog MEAL 3 * For adults SPRING SUMMER Larvae molt that did not into nymph feed in fall WINTER FALL stage • Person • Deer • Dog ADULTS MEAL 3 • Person • Deer • Dog Nymphs dormant Relative abundance of the three major tick stages Connecticut Tick Management Handbook Lyme Transmission • Nymphs account for most human cases: – Only 1 prior blood meal (only 1 chance to acquire B. burgdorferi, while adults have had 2) – Often unrecognized so allowed to feed >24 hours (adults usually removed sooner) Vermont Cases of Lyme Disease by Month of Onset and Status: 2008 - 2011 600 500 400 300 Probable Confirmed Number Casesof Reported Number 200 100 0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month of Onset Vermont Ticks and Pathogens • Deer tick – Lyme disease, anaplasmosis, babesiosis, deer tick virus (Powassan-type virus) • Dog tick – Rocky Mountain spotted fever, tularemia • Woodchuck tick – Powassan virus • Lone star tick – Ehrlichiosis, STARI (southern tick-associated rash illness)) Tick Surveillance Project • Began in 2013 • Surveillance at 12 sites around state – 6 on either side of state • Collect ticks in spring and fall – at least once per site • Test deer ticks for pathogens: – B.burgdorferi, A. phagocytophilum, B. microti • Study leader: Lyndon State College Tick Surveillance – 2013/2014 Vermont Lyme Cases, 2002 – 2014 900 800 700 600 500 400 300 200 100 Number Cases of Number 0 Indigenous - Confirmed Imported/Unknown - Confirmed Indigenous - Probable Imported/Unknown - Probable U.S. Distribution of Lyme Disease 2001 - 2013 Age Distribution Untreated Lyme Disease Often Evolves Through Stages Days Weeks Months Years Early localized • skin • constitutional Early disseminated • skin Symptoms resolve • cardiac Late disease • neurologic • arthritis • neurologic Symptoms resolve Symptoms resolve Early Localized Disease is Characterized by Erythema Migrans • At tick bite site – after 7-14 days – range 3 to 32 days • Occurs in 80% of patients with Lyme • Slowly expanding over days to weeks . homogenous in 59% . central clearing in 9% Tick bite . > 5 cm, up to 20 cm lesion < 5 cm Jones KL. CID.2008;46:85 Mayo Clin Proc 2008;83:566 Erythema Migrans Can Take Many Forms Jones KL. CID.2008;46:85 Mayo Clin Proc 2008;83:566 Early Localized Disease Nonspecific Symptoms • Incubation: 3 to 30 days after tick bite • Constitutional symptoms: – Fatigue 54% – Anorexia 26% – Headache 42% – Neck stiffness 35% – Myalgia 44% – Arthralgia 44% – Regional lymphadenopathy 23% – Fever 16% • Laboratory: – Elevated LFTs 37% – Leukocytosis 5% – Leukopenia 4% Nadelman RB et al. Am J Med 1996:100;502 Early Disseminated Lyme Multiple Erythema Migrans Lesions Early Disseminated Lyme Facial Palsy • lower motor neuron lesion • weakness of both the lower face and forehead • 25% bilateral • HSV, VZV, CMV, EBV • Mycoplasma • HIV • syphilis • stroke • injury Can last for many months • ear disease Early Disseminated Lyme Meningitis • “Aseptic” or viral meningitis-like presentation • Headache, stiff neck, photophobia • Head CT or MRI most often “normal” • Enterovirus • Lumbar puncture: • HSV-2 • lymphocytic pleocytosis • VZV • Mean ~ 160 cells • HIV • elevated protein • Syphilis • Usually < 200- 300 mg% • normal glucose • RMSF • (+) Lyme antibody • Ehrlichia • may be local or from blood • may be long lasting – PCR • low sensitivity Early Disseminated Lyme Radiculopathy • Inflammation at or near the • Can mimic mechanical spinal nerve root radiculopathy • No injury • Imaging studies are usually not revealing • Motor and sensory abnormalities • Pain, numbness, weakness along the dermatones or myotomes • Pain may be on the side of the tick bite Early Disseminated Lyme Cardiac Manifestations • Atrioventricular block • Lyme disease in 875 patients: • 1-2 months (<1 to 28 weeks) • Cardiac manifestations (10%) after the onset of infection • 20% hospitalized • Can occur alone or with • Palpitations, 6.6% erythema migrans, neurologic • Conduction block, 1.8% symptoms • Myocarditis, 0.9 % • Lightheadedness, syncope, shortness of breath, • LV failure, 0.5 % palpitations, and/or chest • Pericarditis, 0.2% pain Late Disease Lyme Disease Rheumatologic and/or Neurologic • Arthritis – knee > shoulder, ankle, elbow, TMJ, wrist – begins abruptly and lasts from several weeks to months – not particularly painful, except from a tensely swollen joint – affected joints are usually very swollen and warm – synovial fluid ~ 24,000 WBC • Neurologic – encephalomyelitis (rare in US, but more common in Europe) – peripheral neuropathy – radiculopathy Lyme Disease is Treatable • Early localized and early disseminated – oral therapy for 14-21 days – doxycycline, amoxicillin, cefuroxime axetil – heart block • ceftriaxone 2g q24h oral x 14-21 days • temporary pacer, if necessary • Arthritis – doxycycline or amoxicillin for 28 days • Meningitis or radiculopathy – ceftriaxone or penicillin x 14-28 days – doxycycline may be adequate • Encephalomyelitis – ceftriaxone for 4 weeks Recovery Is Not always Straight Forward • Complete recovery in majority within ~ 3 wks • Jarisch-Herxheimer reaction in ~ 15% • Improvement may be slow 1,2,3: – more common in disseminated or severe illness – ongoing symptoms in 10 - 15% for > 6 months • fatigue • difficulties with concentration • musculoskeletal pain • no objective findings • no evidence of spirochete replication 1Ann Int Med 2003;138:697, 2Am J Med. 2003;115:91, 3The Lancet 2012;379:46 • Can get re-infected4 4N Engl J Med 2012;367:1883-90 Antibodies to Borrelia Infection Develop and Can be Tested For Acute Infection Chronic Infection IgG False (-) Antibody Titer IgM False (+) • weak bands • increased binding 0 1 2 3 4 5 6 7 8 Weeks Years Antibodies are Detected by Two Tier Testing ELISA • FDA • NIH Whole cell • Council of State and Sonicate Sensitive Territorial Epidemiologists • Association of Public Health Laboratories Western Blot • Clinical Laboratory Standards Institute • Canadian Public Health Specific Laboratory Network IgG (+): 5 of 10 bands • IDSA IgM (+): 2 bands BJB Johnson. Lyme Diseases: Evidence Based Approach. Ed Halperin. 2011 How Good is the Two Tier Test? (+) indeterminate (-) The sensitivity of 2-tier testing in patients with later manifestations of Lyme disease was 100% and the specificity was 99% Steere et al CID 2008:47 (15 July). Chronic Symptoms are often Incorrectly Attributed to Ongoing Active Infection Persistent Lyme disease Treatment symptoms • Fatigue • Pain • Cognitive Post Lyme Treatment Syndrome impairment • How common are these symptoms post treatment? • Are the spirochetes still alive ? This is not “chronic” active • Do prolonged courses of antibiotics help? Borrelia • If not due to infection, then what? infection Are Spirochetes Still Alive After Treatment? • Animal studies have shown that antibiotics cure B. burgdorferi infection even those that are highly immunocompromised1,2,3 • In humans, B. burgdorferi can be cultured from skin lesions prior to treatment but not afterwards4 • In none of the 843 specimens of blood or CSF, tested by culture or PCR, from the 129 patients enrolled in two of the controlled treatment trials could B. burgdorferi be detected5,6 National Institute of Allergy and Infectious Diseases7 Despite extensive study, no clear evidence has emerged to support the contention that post treatment Lyme syndrome results from persistent spirochete infection. N Engl J Med 2007;357:1422-30 4Am J Med 1993;94:583 1 Antimicrob Agents Chemother 1996; 40:2632–6. 5 N Engl J Med 2001;345:85-92 2 Antimicrob Agents Chemother 2002; 46:132–4 6 Vector Borne Zoonotic Dis 2002;2(4):255-63 3 Antimicrob Agents Chemother 1994; 38:1567–72 7 www3.niaid.nih.gov/topics/lymeDisease/understanding/chronic.htm Are Post Treatment Symptoms due to Immune Dysregulation? During the first visit, prior to antibiotic therapy A subset of patients with EM may have immune dysregulation reflected by the persistently elevated levels of IL-23, resulting in post-Lyme disease symptoms. Levels during the first year post therapy Strle et al. CID 2014:58 Do Prolonged Antibiotics Improve Symptoms? All participants had clinically documented Lyme: • Treated • 3 courses, 2 months • Randomized • Persistent symptoms > 6 m • Double blind • 4.6 years • Placebo controlled No iv ceftriaxone x 1 month doxycycline x 2 months 107 difference iv placebo x 1 month placebo pill x 2 months between groups Interfered with functioning • musculoskeletal pain Medical Outcome 36 item General Health Survey • cognitive impairment • fatigue Adverse effects in 25% of antibiotic group: • pulmonary embolism • fever, anemia, GI bleed Klemper et al. • rash, diarrhea,
Recommended publications
  • Tick-Transmitted Diseases
    Deer tick-transmitted infections zoonotic in the eastern U.S. •Lyme disease (Borrelia burgdorferi sensu lato): erythema migrans rash, fever, chills, muscle aches; can progress to arthritis or neurologic signs – 200-500 cases/100,000/year •Babesiosis (Babesia microti): malaria like, fever, chills, muscle aches, fatigue, hemolysis/anemia– 100-200 cases/100,000/year •Human granulocytic ehrlichiosis/anaplasmosis (Anaplasma phagocytophilum): fever, chills, muscle aches, headache—50-100 cases/100,000/year •Borrelia miyamotoi disease (BMD): fever, chills, muscle aches, headache – 50-100 cases/100,000/year •Deer tick virus fever/encephalitis: fever, headache, confusion, seizures– 1-5 cases/100,000/ year Erythema migrans: not just a “bulls-eye” Courtesy of Tim Lepore MD, Nantucket Cottage Hospital Life cycle of deer ticks…critical to develop interventions 40%-70% infection rate 10%-30% infection rate Grace period: Adaptations to extended life cycle Borrelia burgdorferi: 24-48 hours (upregulation of OspC, migration from gut to salivary glands) Babesia microti: 48-62 hours (sporogony from undifferentiated salivary sporoblast) Anaplasma phagocytophilum: 24-36 hours (acquisition of “slime layer”?) Tickborne encephalitis virus: none “Restore the risk landscape to what it was before 1980” The main drivers for emergence of the Lyme disease epidemic: 1905 Pout’s Pond, Deforestation, reforestation: Nantucket dominance of successional habitat Increased development and recreational use in reforested sites Burgeoning deer herds 1986 http://www.ct.gov/caes/lib/caes/documents/publications/bulletins/b1010.pdf
    [Show full text]
  • Transmission and Evolution of Tick-Borne Viruses
    Available online at www.sciencedirect.com ScienceDirect Transmission and evolution of tick-borne viruses Doug E Brackney and Philip M Armstrong Ticks transmit a diverse array of viruses such as tick-borne Bourbon viruses in the U.S. [6,7]. These trends are driven encephalitis virus, Powassan virus, and Crimean-Congo by the proliferation of ticks in many regions of the world hemorrhagic fever virus that are reemerging in many parts of and by human encroachment into tick-infested habitats. the world. Most tick-borne viruses (TBVs) are RNA viruses that In addition, most TBVs are RNA viruses that mutate replicate using error-prone polymerases and produce faster than DNA-based organisms and replicate to high genetically diverse viral populations that facilitate their rapid population sizes within individual hosts to form a hetero- evolution and adaptation to novel environments. This article geneous population of closely related viral variants reviews the mechanisms of virus transmission by tick vectors, termed a mutant swarm or quasispecies [8]. This popula- the molecular evolution of TBVs circulating in nature, and the tion structure allows RNA viruses to rapidly evolve and processes shaping viral diversity within hosts to better adapt into new ecological niches, and to develop new understand how these viruses may become public health biological properties that can lead to changes in disease threats. In addition, remaining questions and future directions patterns and virulence [9]. The purpose of this paper is to for research are discussed. review the mechanisms of virus transmission among Address vector ticks and vertebrate hosts and to examine the Department of Environmental Sciences, Center for Vector Biology & diversity and molecular evolution of TBVs circulating Zoonotic Diseases, The Connecticut Agricultural Experiment Station, in nature.
    [Show full text]
  • The Ecology of New Constituents of the Tick Virome and Their Relevance to Public Health
    viruses Review The Ecology of New Constituents of the Tick Virome and Their Relevance to Public Health Kurt J. Vandegrift 1 and Amit Kapoor 2,3,* 1 The Center for Infectious Disease Dynamics, Department of Biology, The Pennsylvania State University, University Park, PA 16802, USA; [email protected] 2 Center for Vaccines and Immunity, Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA 3 Department of Pediatrics, Ohio State University, Columbus, OH 43205, USA * Correspondence: [email protected] Received: 21 March 2019; Accepted: 29 May 2019; Published: 7 June 2019 Abstract: Ticks are vectors of several pathogens that can be transmitted to humans and their geographic ranges are expanding. The exposure of ticks to new hosts in a rapidly changing environment is likely to further increase the prevalence and diversity of tick-borne diseases. Although ticks are known to transmit bacteria and viruses, most studies of tick-borne disease have focused upon Lyme disease, which is caused by infection with Borrelia burgdorferi. Until recently, ticks were considered as the vectors of a few viruses that can infect humans and animals, such as Powassan, Tick-Borne Encephalitis and Crimean–Congo hemorrhagic fever viruses. Interestingly, however, several new studies undertaken to reveal the etiology of unknown human febrile illnesses, or to describe the virome of ticks collected in different countries, have uncovered a plethora of novel viruses in ticks. Here, we compared the virome compositions of ticks from different countries and our analysis indicates that the global tick virome is dominated by RNA viruses. Comparative phylogenetic analyses of tick viruses from these different countries reveals distinct geographical clustering of the new tick viruses.
    [Show full text]
  • Powassan Virus and Deer Tick Virus Most Tick-Borne Diseases, Such As Lyme, Are Caused by Bacteria
    Powassan Virus and Deer Tick Virus Most tick-borne diseases, such as Lyme, are caused by bacteria. However, with a recent case in New Jersey and discovery in Connecticut blacklegged (deer) ticks, Powassan virus (POWV) has recently come to public attention. Approximately 75 cases of Powassan virus disease were reported in the United States over the past 12 years (103 since 1958) mostly from the Northeast and Great Lakes regions and incidence appears to be increasing. 23 human cases of illness occurred in NY from 1971 to 2016, primarily from the lower Hudson Valley area. Although some people infected with POW do not develop symptoms, it can cause encephalitis (inflammation of the brain) and meningitis (inflammation of the membranes that surround the brain and spinal cord). Other symptoms can include fever, headache, vomiting, weakness, confusion, drowsiness, lethargy, some paralysis, disorientation, loss of coordination, speech difficulties, seizures and memory loss. Long-term neurologic problems may occur and about 10% of cases are fatal. There is no specific treatment, but people with severe POW virus illnesses often need to be hospitalized to receive respiratory support, intravenous fluids, or medications to reduce swelling in the brain. Powassan virus was first identified in 1958 from a young boy in Powassan, Ontario who eventually died from the disease. Related to the West Nile Virus, in North America studies so far suggest POWV is a complex of viruses with two genetic ‘lineages’ including the initial (1958) LB strain and others found in Canada and New York State (POWV, Lineage I), and a second sometimes referred to as ‘deer tick virus’ (DTV, Lineage II), found in animals in the eastern and upper mid-west US and in humans.
    [Show full text]
  • Powassan Virus Experimental Infections in Three Wild Mammal Species
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln USDA National Wildlife Research Center - Staff U.S. Department of Agriculture: Animal and Publications Plant Health Inspection Service 2021 Powassan Virus Experimental Infections in Three Wild Mammal Species Nicole M. Nemeth Colorado State University, [email protected] J. Jeffrey Root USDA APHIS Wildlife Services Airn E. Hartwig Colorado State University Richard A. Bowen Colorado State University Angela M. Bosco-Lauth Colorado State University Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc Part of the Natural Resources and Conservation Commons, Natural Resources Management and Policy Commons, Other Environmental Sciences Commons, Other Veterinary Medicine Commons, Population Biology Commons, Terrestrial and Aquatic Ecology Commons, Veterinary Infectious Diseases Commons, Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Zoology Commons Nemeth, Nicole M.; Root, J. Jeffrey; Hartwig, Airn E.; Bowen, Richard A.; and Bosco-Lauth, Angela M., "Powassan Virus Experimental Infections in Three Wild Mammal Species" (2021). USDA National Wildlife Research Center - Staff Publications. 2444. https://digitalcommons.unl.edu/icwdm_usdanwrc/2444 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA National Wildlife Research Center - Staff Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Am. J. Trop. Med. Hyg., 104(3), 2021, pp. 1048–1054 doi:10.4269/ajtmh.20-0105 Copyright © 2021 by The American Society of Tropical Medicine and Hygiene Powassan Virus Experimental Infections in Three Wild Mammal Species Nicole M.
    [Show full text]
  • By Virus Screening in DNA Samples
    Figure S1. Research of endogeneous viral element (EVE) by virus screening in DNA samples: comparison of Cp values results obtained when detecting the viruses in DNA samples (Light gray) versus Cp values results obtained in the corresponding RNA samples (Dark gray). *: significative difference with p-value < 0.05 (T-test). The S segment of the LTV were found in only one DNA sample and in the corresponding RNA sample. KTV has been detected in one DNA sample but not in the corresponding RNA sample. Figure S2. Luciferase activity (in LU/mL) distribution of measures after LIPS performed in tick/cattle interface for the screening of antibodies specific to Lihan tick virus (LTV), Karukera tick virus (KTV) and Wuhan tick virus 2 (WhTV2). Positivity threshold is indicated for each antigen construct with a dashed line. Table S1. List of tick-borne viruses targeted by the microfluidic PCR system (Gondard et al., 2018) Family Genus Species Asfarviridae Asfivirus African swine fever virus (ASFV) Orthomyxoviridae Thogotovirus Thogoto virus (THOV) Dhori virus (DHOV) Reoviridae Orbivirus Kemerovo virus (KEMV) Coltivirus Colorado tick fever virus (CTFV) Eyach virus (EYAV) Bunyaviridae Nairovirus Crimean-Congo Hemorrhagic fever virus (CCHF) Dugbe virus (DUGV) Nairobi sheep disease virus (NSDV) Phlebovirus Uukuniemi virus (UUKV) Orthobunyavirus Schmallenberg (SBV) Flaviviridae Flavivirus Tick-borne encephalitis virus European subtype (TBE) Tick-borne encephalitis virus Far-Eastern subtype (TBE) Tick-borne encephalitis virus Siberian subtype (TBE) Louping ill virus (LIV) Langat virus (LGTV) Deer tick virus (DTV) Powassan virus (POWV) West Nile virus (WN) Meaban virus (MEAV) Omsk Hemorrhagic fever virus (OHFV) Kyasanur forest disease virus (KFDV).
    [Show full text]
  • A New Tick-Borne Encephalitis-Like Virus Infecting New England Deer Ticks, Ixodes Dammini1
    Dispatches A New Tick-borne Encephalitis-like Virus Infecting New England Deer Ticks, Ixodes dammini1 To determine if eastern North American Ixodes dammini, like related ticks in Eurasia, maintain tick-borne encephalitis group viruses, we analyzed ticks collected from sites where the agent of Lyme disease is zoonotic. Two viral isolates were obtained by inoculating mice with homogenates from tick salivary glands. The virus, which was described by reverse transcriptase polymerase chain reaction and direct sequencing of the amplification products, was similar to, but distinct from, Powassan virus and is provisionally named “deer tick virus.” Enzootic tick-borne encephalitis group viruses accompany the agents of Lyme disease, babesiosis, and granulocytic ehrlichiosis in a Holarctic assemblage of emergent deer tick pathogens. American zoonotic foci of the agents of Lyme humidified chamber until dissection, no more disease (Borrelia burgdorferi, a spirochete) and than 1 month after they were removed from hosts. human babesiosis (Babesia microti, a protozoon) Each field-derived tick was dissected into a were first recognized in coastal New England and drop of sterile Hanks Balanced Salt Solution with the northern Great Plains during the 1960s and 15% fetal bovine serum (HBSS/FBS), and one of 1970s (1). Human granulocytic ehrlichiosis (caused its salivary glands was stained by the Feulgen by rickettsia, Ehrlichia microti or Ehrlichia reaction (8). The corresponding gland was pooled phagocytophila/equi [2]) joined this guild (3) of in 0.5 mL HBSS/FBS with that from four other deer tick-transmitted pathogens (Ixodes dammini ticks and was homogenized; 0.4 mL of each pool [4,5]) during the 1990s.
    [Show full text]
  • Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease
    Article DOI: https://doi.org/10.3201/eid2308.161971 Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease Technical Appendix On all specimens, we performed screening tick-borne encephalitis virus complex IgM and IgG enzyme immunoassays (EUROIMMUN, Mountain Lakes, NJ, USA) and an in-house, 2- tiered Lyme serologic analysis that included an enzyme immunoassay followed by an IgM and IgG immunoblot on enzyme immunoassay–positive specimens per Centers for Disease Control and Prevention recommendations. Samples with positive tick-borne encephalitis virus complex enzyme immunoassays results were followed up by using Powassan virus (POWV) IgG and IgM immunofluorescence antibody (IFA) assays (Coppe Laboratories, Waukesha, WI, USA) (1). The screening dilutions used for the IgM (1:20) and IgG (1:40) POWV IFA assays were based on validation studies (1). We validated the POWV IFA assay results with the following specimens: >90% plaque reduction neutralization test (PRNT90)–confirmed, POWV antibody–positive samples provided by the New York State Department of Health; a human heterologous flavivirus sample set (EUROIMMUN; SeraCare, Milford, MA, USA); and yellow fever virus 17D vaccine recipient serum samples (1). Samples identified as having POWV antibodies by IFA assay were sent to the New York State Department of Health for PRNT90 testing. All samples positive for POWV IgM and all tickborne disease patient samples positive for IgG were tested by reverse transcription PCR (RT- PCR) assay for the presence of POWV glycoprotein E gene. If positive for E, a confirmatory RT- PCR for deer tick virus nonstructural protein 5 (sense 5-AACATGATGGGAAAGAGAGAG-3, antisense 5-CAGATCCTTCGGTACATGGAA-3; Coppe Laboratories) was performed (2).
    [Show full text]
  • Surveillance Summary 2014
    Michigan Zoonotic & Vector-Borne Disease SURVEILLANCE SUMMARY 2014 June, 2015 Michigan Department of Health and Human Services . Michigan Zoonotic and Vector-borne Disease SURVEILLANCE SUMMARY, 2014 Prepared by the Michigan Department of Health and Human Services Bureau of Disease Control, Prevention, and Epidemiology Emerging & Zoonotic Infectious Disease Section (EZID) th 201 Townsend St., 5 Floor Lansing, MI 48913 (517) 335-8165 Created July 2015 Emerging & Zoonotic Infectious Disease Section (EZID) Mary Grace Stobierski, DVM, MPH, DACVPM –Manager, State Public Health Veterinarian Kim Signs, DVM –Zoonotic Disease Epidemiologist Erik Foster, MS –Medical Entomologist Rebecca Reik, MPH –ID Epidemiologist Veronica Fialkowski, MPH –CDC/CSTE Applied Epidemiology Fellow www.michigan.gov/emergingdiseases June, 2015 Michigan Department of Health and Human Services . Michigan Zoonotic and Vector-borne Disease SURVEILLANCE SUMMARY, 2014 Prepared by the Michigan Department of Health and Human Services Bureau of Disease Control, Prevention, and Epidemiology Emerging & Zoonotic Infectious Disease Section (EZID) th 201 Townsend St., 5 Floor Lansing, MI 48913 (517) 335-8165 Created July 2015 Emerging & Zoonotic Infectious Disease Section (EZID) Mary Grace Stobierski, DVM, MPH, DACVPM –Manager, State Public Health Veterinarian Kim Signs, DVM –Zoonotic Disease Epidemiologist Erik Foster, MS –Medical Entomologist Rebecca Reik, MPH –ID Epidemiologist Veronica Fialkowski, MPH –CDC/CSTE Applied Epidemiology Fellow www.michigan.gov/emergingdiseases June,
    [Show full text]
  • Michigan Vector-Borne Disease Update
    Michigan Vector-Borne Disease Update Jennifer Sidge, DVM, PhD Medical Ecologist 2019 MEHA Annual Education Conference March 21, 2019 Putting people first, with the goal of helping all Michiganders lead healthier and more productive lives, no matter their stage in life. Why do we care? ❑ Mosquito-borne diseases are present in Michigan every year and present a serious risk to human and animal health. ❑ Mosquito Control is one of the foundations of preventive public health practice. ❑ MDHHS performs and supports human and ecologic surveillance for mosquito-borne disease in order to inform the public, healthcare providers, and stakeholder agencies about preventive measures and control options. Mosquito-borne virus illness ▪ Generally 3-15 days incubation period ▪ Symptoms range from acute febrile illness, to painful arthritis, to neuro- invasive disease and hemorrhage ▪ Depend upon age, medical history, etc. ▪ Various viruses with different abilities to cause clinical illness ▪ West Nile: 1 in 5 morbidity/<1% severe/3-15% severe illness results in death ▪ EEE: rare, but high mortality ~33% ▪ Chikungunya: >70% morbidity, rarely fatal ▪ Zika: mild clinical illness, but may cause severe birth defects ▪ Treatment is supportive Neuro-invasive disease Is an inflammation of the brain, or meninges with symptoms ranging from mild to acute, both physical and mental. ◦ Headaches ◦ Neck pain ◦ Fever ◦ Confusion ◦ Irritability ◦ Tremors ◦ Coma ◦ Death Michigan mosquito-borne diseases Endemic Diseases West Nile Virus St. Louis Encephalitis Zoonotic Eastern
    [Show full text]
  • Flavivirus Persistence in Wildlife Populations
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 12 August 2021 Review Flavivirus Persistence in Wildlife Populations Maria Raisa Blahove 1 and James Richard Carter 1,* 1 Department of Chemistry and Biochemistry, Georgia Southern University, P.O. Box 8064, Statesboro, GA 30460, United States; [email protected] * Correspondence: [email protected] Abstract: A substantial number of humans are at risk for infection by vector-borne flaviviruses, re- sulting in considerable morbidity and mortality worldwide. These viruses also infect wildlife at a considerable rate, persistently cycling between ticks/mosquitoes to small mammals and reptiles to non-human primates and humans. Substantially increasing evidence of viral persistence in wild- life continue to be reported. In addition to in humans, viral persistence has been shown to establish in mammalian, reptile, arachnid, and mosquito systems, as well as insect cell lines. Although a considerable amount of research has centered on the potential roles defective virus particles, au- tophagy and/or apoptosis induced evasion of the immune response, and the precise mechanism of these features in flavivirus persistence have yet to be elucidated. In this review, we present find- ings that aid in understanding how vector-borne flavivirus persistence is established in wildlife. Research studies to be discussed include determining the critical roles universal flavivirus non- structural proteins played in flaviviral persistence, the advancement of animal models of viral per- sistence, and studying host factors that allow vector-borne flavivirus replication without destructive effects on infected cells. These findings underscore the viral–host relationships in wildlife animals and could be used to elucidate the underlying mechanisms responsible for the establishment of viral persistence in these animals.
    [Show full text]
  • Tick-Borne Encephalitis Virus Complex • Aerosol Hazard in Laboratory
    Tick-Borne Encephalitis Virus Complex • Aerosol hazard in laboratory Disease Agents: Likelihood of Secondary Transmission: • Tick-borne encephalitis virus (TBEV) • Unlikely • Powassan virus (POWV) / deer tick virus (DTV) At-Risk Populations: • Other potentially relevant members of the TBEV complex include Kyasanur Forest disease virus (KFDV) and its related • Forestry workers, farmers, military, outdoor enthusiasts variant Alkhurma virus (ALKV), and Omsk hemorrhagic Vector and Reservoir Involved: fever virus (OHFV) • Ixodes ricinus (Western Europe); I. persulcatus (eastern Disease Agent Characteristics: Eurasia); I. ovatus (China and Japan); I. cookei (North • Family: Flaviviridae; Genus: Flavivirus; Species: TBEV (sub- America) types: European, Far Eastern, and Siberian); POWV/DTV • Dermacentor species and Haemaphysalis species also impli- • Virion morphology and size: Enveloped, polyhedral nucleo- cated vectors in Ixodes-free areas capsid symmetry, spherical particles, 40-60 nm in diameter • Maintained in nature in small wild vertebrate hosts (rodents • Nucleic acid: Linear, positive-sense, single-stranded RNA, and insectivores); large mammals, such as goats, sheep, and ~11.0 kb in length cattle are a less important source of infection • Physicochemical properties: Nonionic detergents solubilize • POWV is maintained primarily in a woodchuck-mustelid-I. the entire envelope; infectivity sensitive to acid pH and high cookei cycle; humans infrequently come into contact with temperatures (total inactivation at 56°C for 30 min); virus infectious ticks that are found only rarely outside of the stable at low temperatures, especially at -60°C or below; burrows of their host animal; generations of ticks are associ- aerosol hazard noted; virus inactivated by UV light, gamma- ated with a single animal. This tick behavior is referred to as irradiation and disinfectants (relatively more resistant than nidiculous.
    [Show full text]